SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-18-014190
Filing Date
2018-11-13
Accepted
2018-11-13 08:22:34
Documents
64
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cerc10-q20180930.htm 10-Q 1498666
2 EXHIBIT 31.1 q32018cercex-311.htm EX-31.1 12635
3 EXHIBIT 31.2 q32018cercex-312.htm EX-31.2 12631
4 EXHIBIT 32.1 q32018cercex-321.htm EX-32.1 11600
  Complete submission text file 0001628280-18-014190.txt   9157145

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cerc-20180930.xml EX-101.INS 1984810
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cerc-20180930.xsd EX-101.SCH 69851
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cerc-20180930_cal.xml EX-101.CAL 110316
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cerc-20180930_def.xml EX-101.DEF 404422
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cerc-20180930_lab.xml EX-101.LAB 917352
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cerc-20180930_pre.xml EX-101.PRE 550533
Mailing Address 400 E. PRATT ST. SUITE 606 BALTIMORE MD 21202
Business Address 400 E. PRATT ST. SUITE 606 BALTIMORE MD 21202 410-522-8707
Cerecor Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37590 | Film No.: 181175306
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1